Premium
A randomised crossover trial of chemotherapy in the home: patient preferences and cost analysis
Author(s) -
Bydder Sean A
Publication year - 2001
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2001.tb143292.x
Subject(s) - citation , crossover study , crossover , test (biology) , medicine , library science , computer science , alternative medicine , artificial intelligence , pathology , placebo , paleontology , biology
ャエ 。ャ or pOl tnltal vaccination with MMR do notrequire serologicalエ セウ エゥョ ァ for measles befo re vaccinatio n. Althoughboth V1l.ccinn ャ セ given to provide rs free of charge for pub liclyfunded vac ination programs, MMR vaccine COM S me Victo rian Department of H um an Services almOSl twice l§ much IS monovalent イ オ 「 セ ャQ 。 vaccine. However, we believethar providing women in thishard-to-reach 。 ァセ gro up al highe r risk of ュ セ 。 ウャ 」ウ terecuce with pro rec rion agains t エィ イ ・ セ diseases, with out the need for new or additional infras tructure or program costs, is an efficient uscof public hea lthresourc es, There is no obviousreason for me continued usc ofmonovetemrubella vaccine for you n g adult women . We suggest th ai health care pr oviders review their usc: of monovalent ru bella vaccine and co nsi der using MMR vaccinesmstead .In addition, State health dep artmentsshould review the currmt policy of making monovalentrubena vaccine ro utine ly avai lable.